← Leaderboards
Riti Sharan
Texas Biomedical Research Institute
$2,085,261
Attributed
$2,085,261
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $718.8K · FY2021–24$1M$750K$500K$250K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,085,261 · 3
By mechanism
R21$799,839 · 1
R56$718,758 · 1
K01$566,664 · 1
Top collaborators
No co-investigators on record.
Most similar at Texas Biomedical Research Institute
Same institution · by research overlap
- Jordi B Torrelles$9,280,507
- Genesio Karere$956,504
Others in their field
Other Emerging Leaders on “Co-Infection”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Thomas Denny · Duke University$23,095,705
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,639,518
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$15,395,607
- Kevin Urdahl · Seattle Children'S Hospital$14,358,263
- Sara Albert · Leidos Biomedical Research, Inc.$9,235,930
Research focus
Co-InfectionHigh RiskProductionTuberculosisHiv/TbHiv InfectionsImmune ResponsePreventLungResponseInfectionMycobacterium TuberculosisAntiretroviral TherapyImmune ActivationCellsCd4 Positive T LymphocytesMacacaCombinatorialCohortMacrophageChronicInsightDendritic CellsBronchoalveolar Lavage
Grant awards (6)
Effect of IL-21 treatment concurrent to ART and 3HP in Mtb/SIV co-infection$718,758
R56 · FY2024 · AI · contact PI
Single cell trancriptomics to identify LTBI reactivation markers in TB/HIV co-infection$387,333
R21 · FY2023 · AI · contact PI
Characterizing IL-22 driven chronic immune activation in HIV/TB co-pandemic$188,995
K01 · FY2023 · OD · contact PI
Single cell trancriptomics to identify LTBI reactivation markers in TB/HIV co-infection$412,506
R21 · FY2022 · AI · contact PI
Characterizing IL-22 driven chronic immune activation in HIV/TB co-pandemic$188,956
K01 · FY2022 · OD · contact PI
Characterizing IL-22 driven chronic immune activation in HIV/TB co-pandemic$188,713
K01 · FY2021 · OD · contact PI